Is NSC 609699 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use NSC 609699? Is NSC 609699 safe for nursing mother and child? Does NSC 609699 extracts into breast milk? Does NSC 609699 has any long term or short term side effects on infants? Can NSC 609699 influence milk supply or can NSC 609699 decrease milk supply in lactating mothers?
Answer by DrLact: About NSC 609699 usage in lactation
Most sources consider breastfeeding to be contraindicated during maternal high-dose antineoplastic drug therapy. The manufacturer recommends that women not breastfeed during treatment with NSC 609699 and for 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]
Alternate Drugs
Letrozole(Dangerous)
Cisplatin(Unsafe)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Busulfan(Dangerous)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Exemestane(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Dactinomycin(Dangerous)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Cladribine(Dangerous)
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Vincristine(Dangerous)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Ipilimumab(Unsafe)
Mercaptopurine(Safe)
Cetuximab(Unsafe)
Carboplatin(Dangerous)
Hydroxyurea(Low Risk)
Paclitaxel(Dangerous)
Etoposide(Dangerous)
Fluorouracil(Dangerous)
Nivolumab(Unsafe)
Doxorubicin(Dangerous)
Alemtuzumab(Low Risk)
Vinblastine(Dangerous)
Docetaxel(Dangerous)
Cyclophosphamide(Dangerous)
Rituximab(Low Risk)